Zanamivir
Relenza contains zanamivir, which belongs to a group of medicines called antivirals.
Relenza is used to treat influenza(influenza virus infection), it reduces the severity of symptoms and accelerates recovery.
Relenza is also used to prevent influenza during an epidemic.
Relenza can be used in adults and children over 5 years of age.
Relenza is administered by inhalation (inhalation) into the lungs, as absorption after swallowing is weak. The influenza virus infects the lungs; when Relenza is inhaled, it acts directly on the viruses inside the lungs.
Relenza does not replace influenza vaccination.You should consult your doctor about whether you need to receive an influenza vaccine.
If the patient is taking inhaled medicinesfor asthma or other breathing disorders, they should continue to take them at the usual times.
If Relenza is prescribed at the same time as other inhaled medicines, take these inhaled medicines a few minutes before taking Relenza.
(such as salbutamol) is at hand while taking Relenza.
now or recently, and about any medicines you plan to take, including those available without a prescription.
If you are taking inhaled medicinesfor asthma or breathing disorders, make sure you have read the above warnings.
Vaccination can be performed at any time, even if the patient is taking Relenza, which helps prevent influenza.
There is only limited data on the safety of Relenza in pregnant women. Although there is no evidence that Relenza harms the fetus, it should not be taken during pregnancy unless prescribed by a doctor.
The active substance (zanamivir) may pass into breast milk, so breastfeeding should be avoided while taking Relenza. Consult your doctor - they will decide whether to stop/discontinue treatment with Relenza or stop breastfeeding, depending on what is best for the patient and the child.
Relenza is unlikely to affect the ability to drive or use machines.
Relenza contains a sugar called lactose and milk protein. If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking Relenza.
This medicine should always be taken as directed by your doctor or pharmacist.If you are unsure, consult your doctor or pharmacist.
Relenza is a powder that is inhaled into the lungs through the mouth, using the Diskhaler inhalation device.
The Rotadisk blister pack, which is placed in the Diskhaler inhalation device, contains 4 doses of powder.
The best results are obtained when treatment is started as soon as possible after symptoms appear:
If someone in the household has influenza, to help prevent illness, start taking Relenza as soon as possibleafter contact with that person:
If there is an influenza epidemic in the area,follow your doctor's advice on when to start taking Relenza.
The dosage depends on whether Relenza is being used to treat or prevent influenza.
Adults and children (5 years and older):usually take 2 inhalations (2 doses) 2 times a day for 5 days.
Adults and children (5 years and older):usually take 2 inhalations (2 doses) once a day for 10 days.
Adults and children (5 years and older):take 2 inhalations (2 doses) once a day for up to 28 days.
Accidental overdose of Relenza is unlikely to cause problems. However, if the patient is concerned or does not feel well, especially if they have asthma or other lung problems, they should tell their doctor.
If a dose of Relenza is missed, take it as soon as possible and continue with the treatment as before.
During influenza treatment, it is important to complete the full course(usually 5 days), even if the patient feels better. Otherwise, influenza symptoms may return.
If the patient wants to stop taking Relenza earlier:
they should consult their doctor for advice.
Read these instructions before taking the first dose of Relenza. If the patient is unsure how to use the Diskhaler device, they should consult their pharmacist and review the instructions together.
Like all medicines, Relenza can cause side effects, although not everybody gets them.
Occur less often than 1 in 1000people taking Relenza. Symptoms include:
If any of these symptoms occur:
These side effects are very rare and may occur less often than 1 in 1000people taking Relenza:
Occur less often than 1 in 10people taking Relenza:
Occur less often than 1 in 100people taking Relenza:
Difficulty breathing.In patients with lung diseases (such as asthma or COPD), it may be necessary to monitor them closely while taking Relenza, due to the possibility of these side effects.
If any of these symptoms occur while taking Relenza:
stop taking the medicine and seek medical attention immediately- contact your doctor or the emergency department of the nearest hospital.
While taking Relenza, changes in behavior, such as feeling disoriented or unresponsive, have occurred. Some patients may also experience hallucinations (seeing, hearing, or feeling things that are not real) or seizures, which can lead to loss of consciousness. Parents should be especially aware of these symptoms in their children (young or adolescent) with influenza. These symptoms have also been observed in people with influenza who were not taking Relenza. It is not known whether Relenza had an effect on their occurrence.
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, more information can be gathered on the safety of the medicine.
Side effects can also be reported to the marketing authorization holder.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "EXP".
The expiry date refers to the last day of the month stated. The abbreviation "Lot" means the batch number of the product.
Do not store above 30°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Ask your pharmacist how to dispose of the Diskhaler inhalation device that is no longer needed. This will help protect the environment.
The active substance is zanamivir (5 mg per dose).
The other ingredient is lactose monohydrate (which contains milk protein).
Four doses of Relenza powder are in a silver-colored foil blister pack called Rotadisk. Each dose contains 5 mg of zanamivir.
The powder is inhaled through the mouth using a plastic inhalation device called Diskhaler.
Relenza is available in two pack sizes:
GlaxoSmithKline Trading Services Limited
12 Riverwalk
Citywest Business Campus
Dublin 24
D24 YK11
Ireland
Glaxo Wellcome Production
Zone Industrielle No.2
23 Rue Lavoisier
27000 Evreux
France
GlaxoSmithKline Trading Services Limited
12 Riverwalk,
Citywest Business Campus
Dublin 24
Ireland
GlaxoSmithKline Trading Services Limited
12 Riverwalk
Citywest Business Campus
Dublin 24
Irlandia
To obtain more detailed information, please contact the representative of the marketing authorization holder:
GSK Services Sp. z o.o.
ul. Rzymowskiego 53
02-697 Warszawa
tel. (22) 576-90-00
Date of last revision of the leaflet:January 2025
--------------------------------------------------------------------------------------------------------------------------
Do not disassemble the Diskhaler device before reading the instructions.
Place the Rotadisk on the Diskhaler device's carousel.
The Rotadisk contains four blisters. Each blister contains 5 mg of zanamivir. The standard dose is two blisters (10 mg).
Do not puncture the blister pack before placing it in the Diskhaler device. The blister pack can remain in the Diskhaler device at all times, but it should only be punctured immediately before use.
Keep the Diskhaler device clean. After use, wipe the mouthpiece with a cloth. When not in use, cover the mouthpiece with the blue cap.
If you experience any problems with the Diskhaler device or the Rotadisk blister pack, contact your doctor or pharmacist.
Remove the blue mouthpiece cap. Make sure the mouthpiece inside and outside is clean.
Hold the Diskhaler device by the edges of the body, as shown in the picture, and slide the white mouthpiece tray out to the stop.
The white mouthpiece tray should come out easily.
Make sure the printed side is facing up, and the blisters are facing down. The blisters "fit" into the holes in the carousel.
Hold the Diskhaler device horizontally
The lid must be in the vertical position to puncture the blister pack from both the top and bottom.
The Diskhaler device is now ready for use. Hold it horizontally until you have finished inhaling the dose.
If you are taking other inhaled medicines,read section 2 of this leaflet carefully Using Relenza with inhaled medicines for breathing disorders.
Before putting the Diskhaler device mouthpiece in your mouth. Exhale deeply, holding the Diskhaler device away from your mouth. Do not blow into the Diskhaler device. If you do, the powder will be blown out of the Rotadisk.
Hold the Diskhaler device horizontally
Do not bite the mouthpiece. Do not cover the air intake holes on either side of the mouthpiece.
Hold your breathfor a few more seconds, as long as you can.
Preparing the Diskhaler device for reuse(second part of the dose):
This will rotate the Rotadisk.
Repeat this step until a full blister is in place under the piercing needle.
To take the next inhalation, follow steps 6-7.
After taking the full dose (usually two inhalations):
Wipe the mouthpiece with a cloth and replace the blue mouthpiece cap.It is essential to keep the Diskhaler device clean.
If all four blisters are empty, replace the Rotadisk blister pack in the Diskhaler device and insert a new one, following steps 1-5.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.